Molecular Typing and Resistance Profiles of Vancomycin-Intermediate Staphylococcus aureus in Korea: Results from a National Surveillance Study, 2007-2013
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: To investigate the national molecular epidemiology and resistance profiles of vancomycinintermediate Staphylococcus aureus (VISA), we analyzed the characteristics of methicillin-resistant Staphylococcus aureus (MRSA) collected from clinical samples at tertiary or general hospitals participating in a nationwide surveillance program for VISA and vancomycin-resistant Staphylococcus aureus (VRSA) in Korea during an 12-week period in each year from 2007 to 2013. Methods: VISA was defined by agar dilution, broth dilution and E-test methods with vancomycin minimum inhibitory concentrations of ＞2 μg/mL. All VISA isolates were characterized by multilocus sequence typing, staphylococcal cassette chromosome mec typing, spa typing, accessory gene regulator typing, Diversilab analysis, and antibiogram analysis. Results: Of 109,345 MRSA isolates, 87,354 were screened and 426 isolates were identified as positive on brain heart infusion agar containing 4 μg/mL vancomycin (BHI-V4). Of 426 isolates, 76 isolates were identified as VISA. No VRSA isolates were detected among the isolates. Overall, a total of 6 genotypes were identified among VISA strains and the predominant clones were ST5-II-t2460, ST72-IV-t324, and ST239-III-t037 (44.7%, 15.8%, and 10.5%, respectively). Of note, ST72-IV-t324 clones are known to be a typical community-associated MRSA. ST239-IIIt037 strains were more resistant to trimethoprim-sulfamethoxazole than any other type of strain. ST72- IV-t324 strains were susceptible to all of the antimicrobial agents tested except erythromycin and daptomycin. All of the VISA isolates were susceptible to linezolid and quinupristin-dalfopristin. Conclusion: Although VRSA is still rare, continuous monitoring of VRSA occurrence is needed, as well as VISA prevalence, epidemic clonal shift, and antimicrobial resistance.
Abstract
Background: To investigate the national molecular epidemiology and resistance profiles of vancomycinintermediate Staphylococcus aureus (VISA), we analyzed the characteristics of methicillin-resistant Staphylococcus aureus (MRSA) collected from clinical samples at tertiary or general hospitals participating in a nationwide surveillance program for VISA and vancomycin-resistant Staphylococcus aureus (VRSA) in Korea during an 12-week period in each year from 2007 to 2013. Methods: VISA was defined by agar dilution, broth dilution and E-test methods with vancomycin minimum inhibitory concentrations of ＞2 μg/mL. All VISA isolates were characterized by multilocus sequence typing, staphylococcal cassette chromosome mec typing, spa typing, accessory gene regulator typing, Diversilab analysis, and antibiogram analysis. Results: Of 109,345 MRSA isolates, 87,354 were screened and 426 isolates were identified as positive on brain heart infusion agar containing 4 μg/mL vancomycin (BHI-V4). Of 426 isolates, 76 isolates were identified as VISA. No VRSA isolates were detected among the isolates. Overall, a total of 6 genotypes were identified among VISA strains and the predominant clones were ST5-II-t2460, ST72-IV-t324, and ST239-III-t037 (44.7%, 15.8%, and 10.5%, respectively). Of note, ST72-IV-t324 clones are known to be a typical community-associated MRSA. ST239-IIIt037 strains were more resistant to trimethoprim-sulfamethoxazole than any other type of strain. ST72- IV-t324 strains were susceptible to all of the antimicrobial agents tested except erythromycin and daptomycin. All of the VISA isolates were susceptible to linezolid and quinupristin-dalfopristin. Conclusion: Although VRSA is still rare, continuous monitoring of VRSA occurrence is needed, as well as VISA prevalence, epidemic clonal shift, and antimicrobial resistance.
참고문헌 (34)
- Howden BP, "The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous- VISA", Infect Genet Evol, 21, pp.575~582 (2014)
- Hiramatsu K, "Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility", J Antimicrob Chemother, 40, pp.135~136 (1997)
- Richter SS, "Detection of Staphylococcus aureus isolates with heterogeneous intermediate-level resistance to vancomycin in the United States", J Clin Microbiol, 49, pp.4203~4207 (2011)
- Rybak MJ, "Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007)", J Clin Microbiol, 46, pp.2950~2954 (2008)
- Adam HJ, "Detection and characterization of heterogeneous vancomycinintermediate Staphylococcus aureus isolates in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006", Antimicrob Agents Chemother, 54, pp.945~949 (2010)
- Sun W, "Prevalence and characterization of heterogeneous vancomycinintermediate Staphylococcus aureus isolates from 14 cities in China", Antimicrob Agents Chemother, 53, pp.3642~3649 (2009)
- Kirby A, "Staphylococcus aureus with reduced glycopeptide susceptibility in Liverpool, UK", J Antimicrob Chemother, 65, pp.721~724 (2010)
- Wootton M, "A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital", J Antimicrob Chemother, 47, pp.399~403 (2001)
- Campanile F, "Heteroresistance to glycopeptides in Italian meticillin-resistant Staphylococcus aureus (MRSA) isolates", Int J Antimicrob Agents, 36, pp.415~419 (2010)
- Garnier F, "A 1 year surveillance study of glycopeptideintermediate Staphylococcus aureus strains in a French hospital", J Antimicrob Chemother, 57, pp.146~149 (2006)
- Bartley J, "First case of VRSA identified in Michigan", Infect Control Hosp Epidemiol, 23, pp.480~ (2002)
- Melo-Cristino J, "First case of infection with vancomycin-resistant Staphylococcus aureus in Europe", Lancet, 382, pp.205~ (2013)
- Moravvej Z, "Update on the global number of vancomycin-resistant Staphylococcus aureus (VRSA) strains", Int J Antimicrob Agents, 42, pp.370~371 (2013)
- Walters MS, "Vancomycin-Resistant Staphylococcus aureus - Delaware", MMWR Morb Mortal Wkly Rep, 64, pp.1056~ (2015)
- Tenover FC, "The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus", Clin Infect Dis, 44, pp.1208~1215 (2007)
- van Hal SJ, "The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis", Clin Infect Dis, 54, pp.755~771 (2012)
- 정경태, "Nationwide Surveillance Study of Vancomycin-Intermediate Staphylococcus aureus Strains in Korean Hospitals from 2001 to 2006", Journal of Microbiology and Biotechnology, 20(3), pp.637~642 (2010), 한국미생물·생명공학회
- Enright MC, "Multilocus sequence typing for characterization of methicillinresistant and methicillin-susceptible clones of Staphylococcus aureus", J Clin Microbiol, 38, pp.1008~1015 (2000)
- Harmsen D, "Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management", J Clin Microbiol, 41, pp.5442~5448 (2003)
- Koreen L, "spa typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro- and macrovariation", J Clin Microbiol, 42, pp.792~799 (2004)
- Oliveira DC, "Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus", Antimicrob Agents Chemother, 46, pp.2155~2161 (2002)
- Gilot P, "Analysis of the genetic variability of genes encoding the RNA III-activating components Agr and TRAP in a population of Staphylococcus aureus strains isolated from cows with mastitis", J Clin Microbiol, 40, pp.4060~4067 (2002)
- Shutt CK, "Clinical evaluation of the DiversiLab microbial typing system using repetitive-sequence-based PCR for characterization of Staphylococcus aureus strains", J Clin Microbiol, 43, pp.1187~1192 (2005)
- Chung DR, "Genotype-specific prevalence of heterogeneous vancomycinintermediate Staphylococcus aureus in Asian countries", Int J Antimicrob Agents, 46, pp.338~341 (2015)
- Zhang S, "Systematic review and meta-analysis of the epidemiology of vancomycin-intermediate and heterogeneous vancomycin-intermediate Staphylococcus aureus isolates", PLoS One, 10, pp.e0136082~ (2015)
- Hu J, "Reduced vancomycin susceptibility found in methicillin-resistant and methicillin-sensitive Staphylococcus aureus clinical isolates in Northeast China", PLoS One, 8, pp.e73300~ (2013)
- Liu C, "Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods", Antimicrob Agents Chemother, 47, pp.3040~3045 (2003)
- Havaei SA, "Genetic characterization of methicillin resistant and sensitive, vancomycin intermediate Staphylococcus aureus strains isolated from different iranian hospitals", ISRN Microbiol, 2012, pp.215275~ (2012)
- DeLeo FR, "Communityassociated meticillin-resistant Staphylococcus aureus", Lancet, 375, pp.1557~1568 (2010)
- Chuang YY, "Molecular epidemiology of community- associated meticillin-resistant Staphylococcus aureus in Asia", Lancet Infect Dis, 13, pp.698~708 (2013)
- Park SH, "Emergence of community-associated methicillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated bloodstream infections in Korea", Infect Control Hosp Epidemiol, 30, pp.146~155 (2009)
- Eun-Jeong Joo, "Characteristics of the community-genotype sequence type 72 methicillin- resistant Staphylococcus aureus isolates that underlie their persistence in hospitals", The Journal of Microbiology, 54(6), pp.445~450 (2016), 한국미생물학회[DOI]
- Prakash V, "Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used", Antimicrob Agents Chemother, 52, pp.4528~ (2008)
- Sader HS, "Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus", Antimicrob Agents Chemother, 53, pp.3162~3165 (2009)